Salveo Capital — 2016 Investments
1 investments dated 2016 · listed companies and verified rows first · show all
PathogenDxpathogendx.comin𝕏Apr 2016
PathogenDx provides molecular pathogen detection assays using proprietary D3 Technology for rapid, multiplexed identification of bacterial, fungal, and viral pathogens in food, agricultural, clinical, and environmental samples.
BiotechFoodTechMedical DevicesScottsdale, US
Michael Hogan(CSO)Milan Patel(CEO)Eric Lachance(COO)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.